1-Azido-23-bromo-3,6,9,12,15,18,21-heptaoxatricosane
1-Azido-23-bromo-3,6,9,12,15,18,21-heptaoxatricosane Basic information
- Product Name:
- 1-Azido-23-bromo-3,6,9,12,15,18,21-heptaoxatricosane
- Synonyms:
-
- 1-Azido-23-bromo-3,6,9,12,15,18,21-heptaoxatricosane
- N3-PEG7-CH2CH2Br
- N3-PEG7-CH2CH2Br/3,6,9,12,15,18,21-Heptaoxatricosane, 1-azido-23-bromo-
- CAS:
- 1056969-61-9
- MF:
- C16H32BrN3O7
- MW:
- 458.35
- Mol File:
- 1056969-61-9.mol
1-Azido-23-bromo-3,6,9,12,15,18,21-heptaoxatricosane Chemical Properties
- storage temp.
- 2-8°C, sealed storage, away from moisture
- form
- Liquid
- color
- Colorless to light yellow
1-Azido-23-bromo-3,6,9,12,15,18,21-heptaoxatricosane Usage And Synthesis
Uses
Bromo-PEG7-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Bromo-PEG7-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
Biological Activity
Bromo-PEG7-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].
IC 50
PEGs
References
[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1-Azido-23-bromo-3,6,9,12,15,18,21-heptaoxatricosaneSupplier
- Tel
- 400-164-7117 13681763483
- product02@bidepharm.com
- Tel
- 400-8592883
- sales@huatengsci.com
- Tel
- 027-65563561
- sales@borenpharm.com
- Tel
- 0512-56316828
- info@amateksci.com
- Tel
- 021-61469567 13482353728
- sales@fdc-chemical.com